These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inhibition of the classical and alternative pathways of human and guinea pig complement by pyran copolymer. Webster GF, McArthur WP. Int Arch Allergy Appl Immunol; 1981; 66(3):304-9. PubMed ID: 6913544 [Abstract] [Full Text] [Related]
8. Cytotoxicity of human serum for Leishmania donovani amastigotes: antibody facilitation of alternate complement pathway-mediated killing. Hoover DL, Berger M, Oppenheim MH, Hockmeyer WT, Meltzer MS. Infect Immun; 1985 Jan; 47(1):247-52. PubMed ID: 3917426 [Abstract] [Full Text] [Related]
9. Inhibition of immune precipitation by complement. Hong K, Takata Y, Sayama K, Kozono H, Takeda J, Nakano Y, Kinoshita T, Inoue K. J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294 [Abstract] [Full Text] [Related]
10. Effect of zinc on lysis of sheep erythrocytes by guinea pig C4-deficient serum. Evans BD, Amiraian K. Mol Immunol; 1987 Dec; 24(12):1345-50. PubMed ID: 3431554 [Abstract] [Full Text] [Related]
11. Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells. Juhl H, Petrella EC, Cheung NK, Bredehorst R, Vogel CW. Immunobiology; 1997 Nov; 197(5):444-59. PubMed ID: 9413745 [Abstract] [Full Text] [Related]
12. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. Pinckard RN, Olson MS, Giclas PC, Terry R, Boyer JT, O'Rourke RA. J Clin Invest; 1975 Sep; 56(3):740-50. PubMed ID: 808560 [Abstract] [Full Text] [Related]
13. Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption. Snyderman R, Pike MC. Infect Immun; 1975 Feb; 11(2):273-9. PubMed ID: 46215 [Abstract] [Full Text] [Related]
14. Complement activation by measles virus cytotoxic antibodies: alternative pathway C activation by hemagglutination-inhibition antibodies but classical activation by hemolysin antibodies. Ehrnst AC. J Immunol; 1977 Feb; 118(2):533-9. PubMed ID: 402419 [Abstract] [Full Text] [Related]
15. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model. Wagner E, Platt JL, Howell DN, Marsh HC, Frank MM. J Immunol; 1999 Sep 15; 163(6):3549-58. PubMed ID: 10477630 [Abstract] [Full Text] [Related]
16. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum. Schreiber AD, Frank MM. J Clin Invest; 1972 Mar 15; 51(3):583-9. PubMed ID: 4622104 [Abstract] [Full Text] [Related]
17. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid. Des Prez RM, Bryan CS, Hawiger J, Colley DG. Infect Immun; 1975 Jun 15; 11(6):1235-43. PubMed ID: 806523 [Abstract] [Full Text] [Related]
18. Studies on the selective lysis and purification of Trypanosoma cruzi. Nogueira N, Bianco C, Cohn Z. J Exp Med; 1975 Jul 01; 142(1):224-9. PubMed ID: 807672 [Abstract] [Full Text] [Related]
19. Alternative complement pathway activation by C4b deposited during classical pathway activation. Matsushita M, Okada H. J Immunol; 1986 Apr 15; 136(8):2994-8. PubMed ID: 2937839 [Abstract] [Full Text] [Related]
20. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement. Nemerow GR, Jensen FC, Cooper NR. J Clin Invest; 1982 Nov 15; 70(5):1081-91. PubMed ID: 6290536 [Abstract] [Full Text] [Related] Page: [Next] [New Search]